NPI: 1407805971 · MCCOMB, MS 39648 · General Acute Care Hospital · NPI assigned 05/10/2006
Authorized official ROWLEY, CHARLA controls 20+ related entities in our dataset. Read more
| Authorized Official | ROWLEY, CHARLA (CEO) |
| NPI Enumeration Date | 05/10/2006 |
Other providers sharing the same authorized official: ROWLEY, CHARLA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 197,354 | $7.91M |
| 2019 | 181,070 | $7.54M |
| 2020 | 167,274 | $5.72M |
| 2021 | 174,720 | $6.52M |
| 2022 | 184,441 | $7.01M |
| 2023 | 197,607 | $6.85M |
| 2024 | 137,543 | $5.07M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 54,427 | 44,360 | $7.55M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 26,598 | 21,269 | $4.29M |
| G0378 | Hospital observation service, per hour | 6,757 | 4,663 | $2.03M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,273 | 7,675 | $2.01M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1,448 | 1,235 | $1.51M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 14,231 | 11,123 | $1.31M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 402 | 334 | $1.20M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 11,933 | 7,949 | $1.19M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 11,456 | 9,941 | $970K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6,730 | 5,694 | $938K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 25,243 | 16,943 | $855K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2,878 | 2,597 | $793K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 5,252 | 2,629 | $781K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2,419 | 2,148 | $754K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 4,156 | 3,742 | $725K |
| 71046 | Radiologic examination, chest; 2 views | 16,562 | 14,006 | $672K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1,400 | 1,250 | $576K |
| D7140 | Extraction, erupted tooth or exposed root | 1,540 | 584 | $540K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 7,468 | 2,675 | $534K |
| J0897 | Injection, denosumab, 1 mg | 945 | 710 | $488K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 14,240 | 2,914 | $483K |
| D2930 | Prefabricated stainless steel crown - primary tooth | 6,714 | 1,371 | $480K |
| 96375 | Therapeutic injection; each additional sequential IV push | 17,507 | 11,125 | $479K |
| 71045 | Radiologic examination, chest; single view | 14,132 | 11,356 | $440K |
| 70450 | Computed tomography, head or brain; without contrast material | 8,666 | 7,524 | $421K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1,713 | 1,438 | $419K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 4,106 | 3,316 | $406K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4,100 | 3,574 | $406K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 12,240 | 10,370 | $401K |
| 59025 | Fetal non-stress test | 3,601 | 2,400 | $368K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8,770 | 7,035 | $364K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 5,465 | 3,934 | $350K |
| 80053 | Comprehensive metabolic panel | 52,591 | 37,962 | $350K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 17,368 | 13,474 | $334K |
| 86900 | 5,579 | 4,393 | $322K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 66,176 | 45,201 | $301K |
| 96361 | Intravenous infusion, hydration; each additional hour | 9,317 | 7,119 | $294K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 13,866 | 10,470 | $270K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2,846 | 2,442 | $270K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 7,055 | 5,186 | $238K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 743 | 466 | $215K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 599 | 546 | $206K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 2,531 | 2,221 | $203K |
| J2505 | Injection, pegfilgrastim, 6 mg | 115 | 83 | $203K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 587 | 516 | $195K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 7,758 | 6,323 | $189K |
| 76801 | 2,878 | 2,231 | $188K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7,739 | 6,313 | $185K |
| 93458 | 165 | 156 | $173K | |
| 96367 | 3,570 | 2,118 | $157K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 275 | 221 | $157K |
| 93017 | 1,892 | 1,674 | $147K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 339 | 293 | $146K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 3,555 | 1,900 | $144K |
| 93976 | 2,365 | 1,949 | $142K | |
| 83880 | 7,685 | 6,150 | $139K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,716 | 1,570 | $137K |
| 43248 | 581 | 526 | $136K | |
| 36415 | Collection of venous blood by venipuncture | 53,792 | 34,445 | $132K |
| 86850 | 5,430 | 4,281 | $131K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 1,838 | 1,102 | $128K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,859 | 1,411 | $123K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,827 | 1,567 | $122K |
| 88312 | 3,954 | 2,928 | $121K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 10,217 | 8,709 | $118K |
| 74018 | 2,809 | 2,441 | $117K | |
| 74019 | 1,920 | 1,665 | $116K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4,507 | 3,766 | $109K |
| 84443 | Thyroid stimulating hormone (TSH) | 10,404 | 8,838 | $109K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 4,893 | 4,208 | $107K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,054 | 863 | $106K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1,599 | 1,428 | $106K |
| 84484 | 16,537 | 10,116 | $105K | |
| J9271 | Injection, pembrolizumab, 1 mg | 30 | 24 | $104K |
| 86901 | 5,575 | 4,391 | $97K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,235 | 1,943 | $95K |
| 72100 | 1,738 | 1,509 | $90K | |
| 81025 | 15,365 | 12,415 | $89K | |
| 73560 | 2,312 | 1,963 | $87K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 622 | 552 | $85K |
| 93226 | 3,265 | 1,670 | $85K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1,006 | 947 | $76K |
| 36430 | 652 | 416 | $76K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 14,077 | 10,309 | $76K |
| 81001 | 37,591 | 29,805 | $74K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 11,206 | 7,547 | $72K |
| 73630 | 1,790 | 1,548 | $71K | |
| J1453 | Injection, fosaprepitant, 1 mg | 849 | 435 | $69K |
| 82553 | 11,682 | 7,187 | $67K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 12,203 | 10,298 | $65K |
| 80061 | Lipid panel | 7,108 | 6,310 | $65K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1,160 | 1,072 | $65K |
| 88313 | 3,497 | 2,880 | $64K | |
| 43235 | 224 | 205 | $64K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 4,053 | 3,518 | $64K |
| 93925 | 877 | 794 | $60K | |
| 73610 | 1,422 | 1,211 | $59K | |
| 86003 | 513 | 385 | $58K | |
| 36600 | 1,939 | 1,570 | $58K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,034 | 909 | $57K |
| 80074 | 1,709 | 1,489 | $56K | |
| 73030 | 1,452 | 1,252 | $52K | |
| 82550 | 12,436 | 7,824 | $51K | |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 44 | 25 | $50K |
| 82805 | 1,627 | 1,271 | $49K | |
| 52214 | 34 | 34 | $48K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 7,122 | 4,885 | $47K |
| C1726 | Catheter, balloon dilatation, non-vascular | 271 | 250 | $46K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 782 | 690 | $45K |
| 82728 | 5,359 | 4,665 | $43K | |
| 73130 | 984 | 855 | $42K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 502 | 400 | $41K |
| 93971 | 995 | 864 | $40K | |
| 86140 | 14,499 | 11,295 | $39K | |
| 83615 | 10,304 | 6,894 | $39K | |
| 88304 | 1,342 | 1,137 | $38K | |
| 97602 | 1,030 | 232 | $38K | |
| 71250 | 965 | 850 | $37K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 878 | 771 | $37K |
| 84702 | 3,453 | 2,445 | $37K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 444 | 392 | $36K |
| 76642 | 1,072 | 928 | $35K | |
| 87807 | 3,238 | 2,829 | $35K | |
| 83690 | 8,397 | 6,707 | $35K | |
| J0517 | Injection, benralizumab, 1 mg | 33 | 25 | $34K |
| 87070 | 5,139 | 4,305 | $34K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 508 | 352 | $33K |
| D4355 | 939 | 759 | $33K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 5,204 | 4,555 | $32K |
| 96415 | 802 | 452 | $32K | |
| 87186 | 5,340 | 4,216 | $32K | |
| 87040 | 5,864 | 3,121 | $31K | |
| 78264 | 195 | 188 | $31K | |
| 83735 | 9,138 | 6,408 | $31K | |
| 87150 | 1,186 | 1,034 | $31K | |
| 95811 | 90 | 76 | $30K | |
| 96417 | 847 | 450 | $30K | |
| 97162 | 706 | 635 | $29K | |
| 82607 | 3,053 | 2,687 | $29K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,139 | 982 | $29K |
| 93922 | 726 | 670 | $28K | |
| D1120 | Prophylaxis - child | 1,974 | 1,647 | $28K |
| 85027 | 6,326 | 4,945 | $27K | |
| 73110 | 617 | 492 | $25K | |
| 97161 | 629 | 552 | $25K | |
| 83550 | 5,222 | 4,573 | $25K | |
| 80081 | 427 | 381 | $24K | |
| 76830 | Ultrasound, transvaginal | 345 | 314 | $24K |
| 10060 | 225 | 197 | $23K | |
| 94762 | 464 | 352 | $23K | |
| Q5120 | Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg | 24 | 12 | $23K |
| 83605 | 4,458 | 3,337 | $22K | |
| 93970 | 255 | 236 | $21K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 290 | 260 | $21K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 121 | 97 | $21K |
| J2469 | Injection, palonosetron hcl, 25 mcg | 213 | 120 | $19K |
| 87088 | 3,645 | 3,003 | $19K | |
| 73502 | 590 | 551 | $19K | |
| 82962 | 10,275 | 6,131 | $19K | |
| 80076 | 3,547 | 2,936 | $18K | |
| 77066 | Tomosynthesis, mammo | 292 | 266 | $18K |
| 84439 | 3,457 | 2,657 | $17K | |
| 85379 | 3,492 | 2,958 | $17K | |
| 77065 | Tomosynthesis, mammo | 394 | 353 | $17K |
| 82746 | 2,023 | 1,789 | $16K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 824 | 715 | $16K |
| 86762 | 1,558 | 1,346 | $16K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 51 | 45 | $16K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 306 | 126 | $16K |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 687 | 385 | $15K |
| 82105 | 1,271 | 1,130 | $15K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 97 | 77 | $15K |
| 88300 | 736 | 618 | $15K | |
| J0185 | Injection, aprepitant, 1 mg | 98 | 53 | $15K |
| 52224 | 14 | 13 | $14K | |
| 77412 | 105 | 12 | $14K | |
| 83540 | 3,737 | 3,211 | $14K | |
| 77336 | 200 | 78 | $13K | |
| 85610 | 5,968 | 4,908 | $13K | |
| 87507 | 63 | 56 | $13K | |
| 82077 | 1,273 | 1,056 | $13K | |
| 70486 | 248 | 218 | $13K | |
| 84153 | 1,496 | 1,284 | $12K | |
| 86592 | 3,906 | 3,422 | $12K | |
| D1208 | Topical application of fluoride, excluding varnish | 1,123 | 905 | $12K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 719 | 315 | $12K |
| 72131 | 311 | 261 | $11K | |
| 87077 | 1,649 | 1,210 | $11K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 509 | 230 | $10K |
| 93880 | 172 | 156 | $10K | |
| 72040 | 325 | 245 | $10K | |
| 86300 | 750 | 595 | $9K | |
| 51702 | 311 | 274 | $9K | |
| 83883 | 703 | 558 | $9K | |
| 12001 | 80 | 74 | $9K | |
| 82565 | 2,014 | 1,769 | $8K | |
| 82677 | 437 | 381 | $8K | |
| 87810 | 309 | 283 | $8K | |
| 86334 | 789 | 654 | $8K | |
| 84165 | 1,638 | 1,277 | $7K | |
| 85730 | 2,288 | 1,943 | $7K | |
| 82784 | 786 | 604 | $6K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 72 | 68 | $6K |
| 96411 | 254 | 128 | $6K | |
| 76770 | 109 | 104 | $6K | |
| 73562 | 153 | 135 | $6K | |
| D1206 | Topical application of fluoride varnish | 567 | 503 | $6K |
| 73590 | 182 | 145 | $6K | |
| 86803 | 840 | 760 | $6K | |
| 84520 | 1,981 | 1,738 | $6K | |
| 86038 | 814 | 716 | $6K | |
| 82803 | 434 | 351 | $6K | |
| 86336 | 437 | 381 | $5K | |
| 87340 | 942 | 828 | $5K | |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | 34 | 31 | $5K |
| 73140 | 145 | 104 | $5K | |
| 85660 | 1,174 | 1,005 | $5K | |
| 83520 | 301 | 251 | $5K | |
| 82330 | 681 | 547 | $4K | |
| 73090 | 114 | 94 | $4K | |
| 86780 | 457 | 399 | $4K | |
| 82378 | 538 | 356 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 175 | 161 | $4K |
| 73070 | 112 | 91 | $4K | |
| 82947 | 1,933 | 1,665 | $4K | |
| J7050 | Infusion, normal saline solution, 250 cc | 7,783 | 3,884 | $4K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 75 | 39 | $3K |
| 86923 | 60 | 39 | $3K | |
| 85651 | 1,255 | 1,050 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 10,533 | 7,515 | $3K |
| 87081 | 581 | 525 | $3K | |
| 84703 | 533 | 435 | $3K | |
| 87427 | 534 | 234 | $3K | |
| 82785 | 236 | 200 | $3K | |
| A6266 | Gauze, impregnated, other than water, normal saline, or zinc paste, sterile, any width, per linear yard | 2,434 | 564 | $2K |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 52 | 30 | $2K |
| 82150 | 506 | 429 | $2K | |
| 82010 | 461 | 355 | $2K | |
| 87045 | 282 | 235 | $2K | |
| 87046 | 271 | 223 | $2K | |
| 84550 | 638 | 499 | $2K | |
| 96523 | 103 | 94 | $2K | |
| 86704 | 371 | 322 | $2K | |
| J0640 | Injection, leucovorin calcium, per 50 mg | 152 | 61 | $2K |
| 76775 | 52 | 42 | $2K | |
| 85045 | 958 | 617 | $2K | |
| 73552 | 49 | 39 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 20,128 | 14,689 | $2K |
| 84132 | 1,195 | 947 | $2K | |
| 81003 | 1,026 | 625 | $2K | |
| 85007 | 984 | 673 | $2K | |
| D2330 | 46 | 24 | $2K | |
| J1756 | Injection, iron sucrose, 1 mg | 376 | 133 | $2K |
| 72072 | 29 | 26 | $2K | |
| 70498 | 38 | 37 | $2K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 430 | 300 | $2K |
| 0240U | 596 | 517 | $1K | |
| A9270 | Non-covered item or service | 10,992 | 6,851 | $1K |
| 82375 | 315 | 253 | $1K | |
| D1351 | Sealant - per tooth | 95 | 60 | $1K |
| J9190 | Injection, fluorouracil, 500 mg | 205 | 74 | $1K |
| 82247 | 255 | 127 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 5,990 | 4,339 | $1K |
| 80069 | 473 | 288 | $1K | |
| 87205 | 436 | 373 | $1K | |
| 82435 | 661 | 530 | $1K | |
| 12011 | 22 | 13 | $942.26 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 2,156 | 1,459 | $931.87 |
| 97165 | 21 | 17 | $922.27 | |
| 84295 | 686 | 557 | $918.38 | |
| 83050 | 315 | 253 | $883.27 | |
| 97163 | 13 | 13 | $801.33 | |
| 93242 | 66 | 62 | $795.83 | |
| 80143 | 62 | 53 | $788.66 | |
| 87210 | 227 | 206 | $767.66 | |
| 82570 | 330 | 273 | $754.33 | |
| 51701 | 16 | 14 | $746.50 | |
| 97014 | 69 | 12 | $733.96 | |
| 70496 | 13 | 12 | $731.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,747 | 2,237 | $681.19 |
| A6253 | Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing | 892 | 266 | $652.88 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 221 | 194 | $641.85 |
| 85014 | 442 | 344 | $628.28 | |
| 80179 | 44 | 39 | $553.74 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 10,704 | 8,974 | $551.15 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 4,320 | 2,675 | $500.28 |
| 82533 | 150 | 71 | $483.81 | |
| G0381 | Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 14 | 13 | $477.35 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,909 | 1,223 | $471.85 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 8,827 | 7,241 | $443.12 |
| C9113 | Injection, pantoprazole sodium, per vial | 1,785 | 988 | $441.00 |
| 85018 | 542 | 435 | $441.00 | |
| 84100 | 295 | 178 | $432.61 | |
| 90756 | 40 | 37 | $398.48 | |
| 82043 | 139 | 136 | $390.41 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 1,420 | 1,271 | $376.92 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 1,340 | 869 | $374.13 |
| 0077U | 938 | 746 | $353.83 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 16 | 13 | $321.92 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 6,942 | 4,882 | $317.84 |
| 82950 | 94 | 77 | $317.13 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 7,297 | 5,504 | $302.95 |
| A6251 | Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 571 | 441 | $290.40 |
| J2785 | Injection, regadenoson, 0.1 mg | 1,004 | 909 | $258.80 |
| 83521 | 1,085 | 650 | $250.15 | |
| 90686 | 19 | 18 | $236.72 | |
| C1769 | Guide wire | 2,298 | 1,801 | $227.33 |
| 91200 | 27 | 27 | $215.26 | |
| 82977 | 42 | 38 | $210.71 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 5,435 | 4,458 | $201.48 |
| 84145 | 3,837 | 2,878 | $194.91 | |
| 84156 | 82 | 63 | $186.10 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 6,516 | 5,518 | $167.25 |
| A9698 | Non-radioactive contrast imaging material, not otherwise classified, per study | 3,643 | 3,134 | $145.86 |
| J3490 | Unclassified drugs | 537 | 436 | $138.74 |
| 96376 | 6,948 | 3,550 | $124.11 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 2,868 | 1,337 | $98.19 |
| A6197 | Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing | 119 | 42 | $96.80 |
| J2060 | Injection, lorazepam, 2 mg | 1,380 | 1,089 | $94.07 |
| J1815 | Injection, insulin, per 5 units | 3,182 | 1,865 | $91.99 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 1,117 | 807 | $88.86 |
| 99152 | 1,342 | 1,147 | $87.79 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 726 | 571 | $81.77 |
| 88302 | 22 | 12 | $79.24 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 156 | 79 | $78.18 |
| J1170 | Injection, hydromorphone, up to 4 mg | 4,955 | 2,951 | $70.94 |
| J0690 | Injection, cefazolin sodium, 500 mg | 2,984 | 2,502 | $69.39 |
| 84155 | 67 | 52 | $66.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 449 | 378 | $60.28 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 492 | 418 | $54.41 |
| 94664 | 5,699 | 3,546 | $47.20 | |
| 86308 | 13 | 12 | $46.00 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 997 | 840 | $43.25 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 226 | 121 | $42.50 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 215 | 161 | $41.56 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 948 | 643 | $41.05 |
| 94760 | 2,240 | 1,418 | $39.17 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 503 | 320 | $37.93 |
| J1940 | Injection, furosemide, up to 20 mg | 1,181 | 639 | $36.60 |
| J1644 | Injection, heparin sodium, per 1000 units | 2,016 | 1,540 | $36.21 |
| 0296T | 12 | 12 | $35.78 | |
| 77061 | 15 | 12 | $32.90 | |
| J3480 | Injection, potassium chloride, per 2 meq | 354 | 224 | $30.38 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 5,188 | 4,195 | $28.56 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 746 | 589 | $25.68 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 329 | 87 | $20.95 |
| A6260 | Wound cleansers, any type, any size | 43 | 38 | $19.36 |
| C1760 | Closure device, vascular (implantable/insertable) | 688 | 584 | $18.41 |
| 90715 | 885 | 783 | $18.38 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,487 | 1,362 | $12.16 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 392 | 341 | $9.77 |
| 77062 | 28 | 25 | $8.58 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 506 | 414 | $7.47 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 228 | 113 | $5.64 |
| J2704 | Injection, propofol, 10 mg | 306 | 156 | $5.47 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 15 | 12 | $4.30 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 140 | 71 | $3.35 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 882 | 509 | $2.79 |
| A6445 | Conforming bandage, non-elastic, knitted/woven, sterile, width less than three inches, per yard | 1,641 | 1,379 | $2.65 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 1,024 | 871 | $1.67 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 106 | 78 | $0.55 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 374 | 220 | $0.16 |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 200 | 191 | $0.00 |
| G8990 | Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals | 21 | 17 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 372 | 319 | $0.00 |
| A6203 | Composite dressing, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing | 612 | 513 | $0.00 |
| L8613 | Ossicula implant | 1,196 | 1,000 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 4,106 | 2,973 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 1,542 | 1,296 | $0.00 |
| 0427U | 809 | 732 | $0.00 | |
| A4332 | Lubricant, individual sterile packet, each | 327 | 246 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 464 | 391 | $0.00 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 198 | 193 | $0.00 |
| J1956 | Injection, levofloxacin, 250 mg | 15 | 12 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 380 | 245 | $0.00 |
| A6403 | Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing | 75 | 69 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 16 | 12 | $0.00 |
| Q9962 | High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml | 106 | 79 | $0.00 |
| 77012 | 13 | 12 | $0.00 | |
| C1729 | Catheter, drainage | 24 | 12 | $0.00 |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | 77 | 52 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 30 | 26 | $0.00 |
| S0077 | Injection, clindamycin phosphate, 300 mg | 27 | 14 | $0.00 |
| 93356 | 25 | 24 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 12 | 12 | $0.00 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 24 | 23 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 39 | 21 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 17 | 13 | $0.00 |
| 36000 | 286 | 213 | $0.00 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 28 | 24 | $0.00 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 116 | 96 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 328 | 268 | $0.00 |
| 81511 | 16 | 14 | $0.00 | |
| 96377 | 46 | 36 | $0.00 | |
| 80050 | General health panel | 66 | 39 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 239 | 195 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 13 | 12 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 71 | 36 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 17 | 13 | $0.00 |
| G8991 | Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 36 | 29 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 95 | 81 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 97 | 69 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 114 | 100 | $0.00 |